Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001906324-25-000057
Filing Date
2025-05-08
Accepted
2025-05-07 17:45:47
Documents
79
Period of Report
2025-03-30

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20250330.htm   iXBRL 10-Q 975274
2 EX-10.1 ex1013302025.htm EX-10.1 71538
3 EX-10.3 ex1033302025.htm EX-10.3 16809
4 EX-10.4 ex1043302025.htm EX-10.4 34024
5 EX-31.1 ex3113302025.htm EX-31.1 9678
6 EX-31.2 ex3123302025.htm EX-31.2 9789
7 EX-32.1 ex3213302025.htm EX-32.1 5583
13 GRAPHIC image.jpg GRAPHIC 2832
  Complete submission text file 0001906324-25-000057.txt   6491178

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20250330.xsd EX-101.SCH 39119
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20250330_cal.xml EX-101.CAL 84811
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20250330_def.xml EX-101.DEF 184831
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20250330_lab.xml EX-101.LAB 549099
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20250330_pre.xml EX-101.PRE 400868
82 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20250330_htm.xml XML 988627
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 10-Q | Act: 34 | File No.: 001-41409 | Film No.: 25923084
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)